Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia-Reference-Cited by-同舟云学术

Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia

Published:2018-07-03 Issue:3 Volume:13 Page:667-672
ISSN:1751-7885
Container-title:Early Intervention in Psychiatry
language:en
Short-container-title:Early Intervention in Psychiatry

Author:

Bell Lynum Karimah S.¹^ORCID,Turkoz Ibrahim²,Kim Edward¹

Affiliation:

1. Janssen Scientific Affairs, LLC Titusville New Jersey

2. Janssen Research & Development, LLC Titusville New Jersey

Funder

Janssen Scientific Affairs, LLC

Publisher

Wiley

Subject

Biological Psychiatry,Psychiatry and Mental health,Pshychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eip.12685

Reference28 articles.

1. Medication adherence in schizophrenia

2. Treatment effect with paliperidone palmitate compared with oral antipsychotics in patients with recent‐onset versus more chronic schizophrenia and a history of criminal justice system involvement;Alphs L.;Early Intervention in Psychiatry,2015

3. Rethinking the role of long‐acting atypical antipsychotics in the community setting;Altamura A. C.;International Clinical Psychopharmacology,2012

4. Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia

5. Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults;Expert Review of Neurotherapeutics;2024-03-06

2. Impact of early use of long-acting injectable antipsychotics on functional outcome in first episode psychosis: a 3-year longitudinal study;International Journal of Psychiatry in Clinical Practice;2022-06-02

3. Impact on functionality of the paliperidone palmitate three-month formulation in patients with a recent diagnosis of schizophrenia: a real-world observational prospective study;Expert Opinion on Pharmacotherapy;2022-01-05

4. Comparative effectiveness of long-acting injectable antipsychotics in a large naturalistic cohort across two European centers: Findings from the long-acting injectable antipsychotics collaborative (LAICO) study.;Neuroscience Applied;2022

5. Comparative Effectiveness of Second Generation Long-acting Injectable Antipsychotics Based on Nationwide Database Research in Hungary: An Update;Schizophrenia Bulletin Open;2022-01-01